2024-08-01 14:59:08
Health
Europe

Pharmaceutical Group Sanofi: €1.3 Billion Investment in Insulin Production in Germany

Image used under license from Shutterstock.com

French pharmaceutical company Sanofi has announced plans to invest €1.3 billion in the construction of a new insulin production facility in Germany. The new facility will replace the current production sites in Höchst, near Frankfurt, and is expected to be completed by 2029. The project aims to ensure the long-term supply of essential insulin for people living with diabetes and strengthen the resilience of European healthcare.

The investment has received support from both the German federal government and the state government of Hesse. Sanofi Germany CEO Heidrun Irschik-Hadjieff described it as an important signal for the biopharmaceutical industry.

This investment follows similar announcements by US pharmaceutical company Eli Lilly, which plans to invest €2.3 billion to expand its diabetes medication production in Germany, and Danish company Novo Nordisk, the leading global insulin manufacturer, which is investing €2.1 billion to expand its production facility in France.

Sanofi's current Höchst site covers the entire insulin production chain, from the manufacturing of the active ingredient to the distribution of injections worldwide.

AFP
1. August 2024 um 11:56

Pharmaceutical Group Sanofi: 1.3 Billion Euros for Insulin Production in Germany

Economy
Finance
Politics
Sanofi is building a 1.3 billion euro insulin plant in Höchst that covers the entire production chain from active ingredient to distribution, with the support of the federal and state governments, as an important signal for the biopharmaceutical industry.
Deutsche Welle
1. August 2024 um 14:30

Sanofi invests 1.3 billion euros in Frankfurt

Economy
Finance
Technology
Sanofi is investing 1.3 billion euros in a new insulin production facility in Frankfurt. The new plant will replace the existing locations and is scheduled to be completed by 2029.
Tagesschau - Wirtschaft und Börsen-Nachrichten
1. August 2024 um 09:57

Sanofi Builds New Insulin Plant in Frankfurt for 1.3 Billion Euros

Economy
Technology
Sanofi is investing 1.3 billion euros in the construction of a new insulin plant in Frankfurt-Höchst. The plant is scheduled to be completed by 2029 and will employ several hundred skilled workers. Sanofi already produces the diabetes drug Lantus, which generates billions in revenue for the company, at this location.
CW

Account

Waiting list for the personalized area


Welcome!

InfoBud.news

infobud.news is an AI-driven news aggregator that simplifies global news, offering customizable feeds in all languages for tailored insights into tech, finance, politics, and more. It provides precise, relevant news updates, overcoming conventional search tool limitations. Due to the diversity of news sources, it provides precise and relevant news updates, focusing entirely on the facts without influencing opinion. Read moreExpand

Your World, Tailored News: Navigate The News Jungle With AI-Powered Precision!